IP Library Granted Patent US 7,713,303
Granted Patent B2
US 7,713,303 · App. 11/117,025 · Granted May 11, 2010

Collagen-based materials and methods for augmenting intervertebral discs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,713,303
App. No.
11/117,025
Granted
May 11, 2010
Kind
B2
Abstract

A method of augmenting an intervertebral disc by injecting particles of collagen-based material into the disc. The particles may be dehydrated before implantation, and rehydrated after implantation, or they may be implanted in a “wet” state—such as a slurry or gel. Radiocontrast materials may be included to enhance imaging of the injected material. Other additives may include analgesics, antibiotics, proteoglycans, growth factors, and/or other cells effective to promote healing and/or proper disc function.

Claims (17)

1. A method of augmenting an intervertebral disc, said method comprising surgically adding to the nucleus of an intervertebral disc an injectable material consisting essentially of small particles of natural tissue selected from the group consisting of intervertebral disc, fascia, ligament, tendon, skin, and other connective tissue.

2. The method of claim 1 wherein said surgically adding step comprises injecting small particles of natural tissue into the nucleus of an intervertebral disc.

3. The method of claim 1 wherein said small particles of natural tissue comprises particles ranging from 0.05 mm to 5 mm in size.

4. The method of claim 1 wherein said small particles of natural tissue comprises particles ranging from 0.05 mm to 3 mm in size.

5. The method of claim 1 wherein said small particles of natural tissue comprises particles ranging from 0.05 mm to 1 mm in size.

6. The method of claim 1 wherein said small particles of natural tissue comprises particles ranging from 0.25 mm to 1 mm in size.

7. The method of claim 1 wherein said small particles of natural tissue are injected in a dehydrated state.

8. The method of claim 1 wherein said small particles of natural tissue are injected in a non-dehydrated state.

9. The method of claim 8 wherein said small particles of natural tissue are injected as a gel.

10. The method of claim 8 wherein said small particles of natural tissue are injected as a solution or suspension.

11. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes a cross-linking agent to promote crosslinking of collagen molecules contained in the small particles of natural tissue.

12. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes a radio contrast media.

13. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes an analgesic.

14. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes an antibiotic.

15. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes proteoglycans.

16. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes growth factors.

17. The method of claim 1 wherein said small particles of natural tissue are provided as a formulation that additionally includes one or more other types of cells effective to promote healing, repair, regeneration and/or restoration of the disc, and/or to facilitate proper disc function.

Assignments (1)
MERGER Recorded Jan 4, 2010
From: SDGI HOLDINGS, INC.
To: WARSAW ORTHOPEDIC, INC.
Reel/Frame 023728/0061 →